Device
Eye Tracker
Eye Tracker is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
unknown1
Completed1
Recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
unknown125%
completed125%
recruiting125%
terminated125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
Clinical Outcome Assessment for AT & BCI
NCT07407725
terminatednot_applicable
Serotonin Role on Brain Circuits Involved in Food Avoidance in Anorexia Nervosa
NCT05155280
completednot_applicable
Role of Self-focused Attention in Depression
NCT05464550
unknown
Impact of Visual Field Restriction on Visual Exploration
NCT04360291
Clinical Trials (4)
Showing 4 of 4 trials
NCT07407725Not Applicable
Clinical Outcome Assessment for AT & BCI
NCT05155280Not Applicable
Serotonin Role on Brain Circuits Involved in Food Avoidance in Anorexia Nervosa
NCT05464550Not Applicable
Role of Self-focused Attention in Depression
NCT04360291
Impact of Visual Field Restriction on Visual Exploration
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4